Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
5 min read
Pharmaceutical Insights: Clemastine Fumarate's R&D Progress and its Mechanism of Action on Drug Target
30 September 2023
This article summarized the latest R&D progress of Clemastine Fumarate, the Mechanism of Action for Clemastine Fumarate, and the drug target R&D trends for Clemastine Fumarate.
Valuable Targets
4 min read
Analysis on the Clinical Research Progress of Prostaglandin Synthases Inhibitors
30 September 2023
Prostaglandin synthases are enzymes that play a crucial role in the human body by catalyzing the synthesis of prostaglandins.
Drug Insights
5 min read
Exploring Ciprofloxacin Hydrochloride's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
30 September 2023
This article summarized the latest R&D progress of Ciprofloxacin Hydrochloride, the Mechanism of Action for Ciprofloxacin Hydrochloride, and the drug target R&D trends for Ciprofloxacin Hydrochloride.
Latest Hotspot
3 min read
Genmab announces EU approval for TEPKINLY® (epcoritamab) to treat adult R/R DLBCL
30 September 2023
Genmab Unveils EU Commission's Authorization for TEPKINLY® (epcoritamab) to Treat Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) in Adults.
Drug Insights
4 min read
Decoding Carboprost Tromethamine: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
30 September 2023
This article summarized the latest R&D progress of Carboprost Tromethamine, the Mechanism of Action for Carboprost Tromethamine, and the drug target R&D trends for Carboprost Tromethamine.
Valuable Targets
6 min read
Advances in Clinical Research on PPAR Agonists
30 September 2023
PPAR, or peroxisome proliferator-activated receptor, is a group of nuclear receptor proteins found in the human body.
Drug Insights
4 min read
Deep Scientific Insights on Carbidopa/Levodopa's R&D Progress, Mechanism of Action, and Drug Target
30 September 2023
This article summarized the latest R&D progress of Carbidopa/Levodopa, the Mechanism of Action for Carbidopa/Levodopa, and the drug target R&D trends for Carbidopa/Levodopa.
Latest Hotspot
3 min read
Lutathera®, a Novartis radioligand therapy, significantly improved progression-free survival rates in early advanced GEP-NETs
30 September 2023
Lutathera®, a radioligand therapy by Novartis, showed significant progression-free survival rates in initial stage advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Drug Insights
4 min read
An In-depth Analysis of Brentuximab Vedotin's R&D Progress and Mechanism of Action on Drug Target
30 September 2023
This article summarized the latest R&D progress of Brentuximab Vedotin, the Mechanism of Action for Brentuximab Vedotin, and the drug target R&D trends for Brentuximab Vedotin.
Valuable Targets
6 min read
Analysis on the Research Progress of Protease inhibitors
30 September 2023
Proteases are enzymes that play a crucial role in the human body by breaking down proteins into smaller peptides or amino acids.
Drug Insights
4 min read
Arformoterol Tartrate: Detailed Review of its Transformative R&D Success
30 September 2023
Arformoterol Tartrate is a small molecule drug that targets the β2-adrenergic receptor. It is primarily used in the treatment of various respiratory diseases.
Latest Hotspot
4 min read
Henlius' Innovative Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Receives Approval for Use in Treating ESCC
30 September 2023
Shanghai Henlius Biotech, Inc. has made a public announcement that the NMPA has given approval to the NDA for an innovative fresh indication of HANSIZHUANG (serplulimab injection).